Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14801 - 14825 of 15219 in total
BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.
Investigational
Matched Description: … BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy. …
Zotarolimus is an immunosuppressant under investigation for use in drug-eluting stents.
Investigational
Matched Description: … Zotarolimus is an immunosuppressant under investigation for use in drug-eluting stents. …
Soblidotin has been used in trials studying the treatment of Sarcoma, Lung Cancer, and Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Matched Iupac: … [(1R,2R)-1-methoxy-2-methyl-2-[(2-phenylethyl)carbamoyl]ethyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4- …
Matched Description: … Soblidotin has been used in trials studying the treatment of Sarcoma, Lung Cancer, and Unspecified Adult …
Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy).
Investigational
Matched Description: … Camrelizumab is under investigation in clinical trial NCT03417895 (SHR-1210 Combined With Apatinib in
Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma).
Investigational
Matched Description: … in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma). ... Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab …
RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.).
Investigational
Matched Description: … Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.). ... RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic …
Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma).
Investigational
Matched Description: … Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma). ... Technetium Tc-99m epratuzumab is under investigation in clinical trial NCT00003337 (Radiolabeled Monoclonal …
Foralumab is under investigation in clinical trial NCT03291249 (Assessment of the Safety of Foralumab, an Oral Anti-cd3 Antibody, in Patients With NASH and T2DM).
Investigational
Matched Description: … , an Oral Anti-cd3 Antibody, in Patients With NASH and T2DM). ... Foralumab is under investigation in clinical trial NCT03291249 (Assessment of the Safety of Foralumab …
Tilsotolimod is under investigation in clinical trial NCT03865082 (Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)).
Investigational
Matched Description: … Tilsotolimod is under investigation in clinical trial NCT03865082 (Study of Tilsotolimod in Combination …
Experimental
Matched Iupac: … {[(2R,3R,4R,5R)-4-hydroxy-5-({[hydroxy({[hydroxy({[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methoxy} …
Investigational
Matched Iupac: … (177Lu)lutetium(3+) 2-[4-({[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1R)-1-{[(1S)-1-{[(1S)-1-[({ ... carbamoyl}-2-carboxyethyl]carbamoyl}pentyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}methyl)carbamoyl]-2-(4- …
Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization/fluoride Uptake in an in Situ Model).
Investigational
Matched Description: … /fluoride Uptake in an in Situ Model). ... Isopentane is under investigation in clinical trial NCT00752089 (Experimental Dentifrice Remineralization …
Davalintide is under investigation in clinical trial NCT00785408 (Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects).
Investigational
Matched Description: … and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects). ... Davalintide is under investigation in clinical trial NCT00785408 (Study to Examine Safety, Tolerability …
Sisunatovir is under investigation in clinical trial NCT04267822 (Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV).
Investigational
Matched Description: … Sisunatovir is under investigation in clinical trial NCT04267822 (Study of RV521 in the Treatment of …
N-(3-carboxypropanoyl)-L-norvaline is a solid. This compound belongs to the n-acyl-alpha amino acids. These are compounds containing an alpha amino acid which bears an acyl group at his terminal nitrogen atom. This medication is known to target n-acetylornithine carbamoyltransferase and putative ornithine carbamoyltransferase.
Experimental
Matched Description: … N-(3-carboxypropanoyl)-L-norvaline is a solid. …
Censavudine has been used in trials studying the treatment of HIV-1 Infection.
Investigational
Matched Description: … Censavudine has been used in trials studying the treatment of HIV-1 Infection. …
Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury.
Investigational
Matched Description: … Oxycyte has been used in trials studying the treatment of Traumatic Brain Injury. …
GSI-136 has been used in trials studying the treatment of Alzheimer Disease.
Investigational
Matched Description: … GSI-136 has been used in trials studying the treatment of Alzheimer Disease. …
Pirnabine has been used in trials studying the treatment of Chronic Idiopathic Constipation.
Investigational
Matched Description: … Pirnabine has been used in trials studying the treatment of Chronic Idiopathic Constipation. …
Rontalizumab has been used in trials studying the treatment of Systemic Lupus Erythematosus.
Investigational
Matched Description: … Rontalizumab has been used in trials studying the treatment of Systemic Lupus Erythematosus. …
Epitizide is an agent, commonly found in combination triamterene, used to produce diuresis.
Experimental
Matched Description: … Epitizide is an agent, commonly found in combination [triamterene], used to produce diuresis. …
Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)).
Investigational
Matched Description: … Tigatuzumab is under investigation in clinical trial NCT00991796 (CS-1008 With Carboplatin/Paclitaxel ... in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC)). …
Nimacimab is under investigation in clinical trial NCT03261739 (Safety Tolerability, and PK of RYI-018 After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)).
Investigational
Matched Description: … After Repeat Dosing in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)). ... Nimacimab is under investigation in clinical trial NCT03261739 (Safety Tolerability, and PK of RYI-018 …
Iscalimab is under investigation in clinical trial NCT03905525 (Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome).
Investigational
Matched Description: … Doses of CFZ533 in Two Distinct Populations of Patients With Sjögren's Syndrome). ... Iscalimab is under investigation in clinical trial NCT03905525 (Study of Safety and Efficacy of Multiple …
Hypothiocyanite ion is under investigation in clinical trial NCT02598999 (Dose Escalation Study of ALX-009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients).
Investigational
Matched Description: … -009 in Healthy Men and Cystic Fibrosis (CF) and Non-CF Bronchiectasis Patients). ... Hypothiocyanite ion is under investigation in clinical trial NCT02598999 (Dose Escalation Study of ALX …
Displaying drugs 14801 - 14825 of 15219 in total